Skip to content

ALPINE IMMUNE SCIENCES, INC.: filings

Every ALPINE IMMUNE SCIENCES, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 36 filings, each linked to its SEC index.

Filing record ends 2024-05-09

The latest filing in this captured record is a 10-Q filed 2024-05-09. No later filing is in the SEC companyfacts record captured on 2026-09-22. ALPINE IMMUNE SCIENCES, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-05-09fiscal Q1 202439820001626199-24-000064
10-K2024-03-20fiscal FY 2023481260001626199-24-000048
10-Q2023-11-14fiscal Q3 2023421270001626199-23-000126
10-Q2023-08-14fiscal Q2 2023421230001626199-23-000088
10-Q2023-05-11fiscal Q1 202342880001626199-23-000076
10-K2023-03-23fiscal FY 2022491270001626199-23-000037
10-Q2022-11-14fiscal Q3 2022451310001626199-22-000080
10-Q2022-08-11fiscal Q2 2022441250001626199-22-000057
10-Q2022-05-12fiscal Q1 202243890001626199-22-000045
10-K2022-03-17fiscal FY 2021481230001626199-22-000032
10-Q2021-11-10fiscal Q3 2021421250001626199-21-000143
10-Q2021-08-10fiscal Q2 2021421190001626199-21-000100
10-Q2021-05-13fiscal Q1 202133690001626199-21-000059
10-K2021-03-18fiscal FY 2020421050001626199-21-000038
10-Q2020-11-12fiscal Q3 2020371080001626199-20-000057
10-Q2020-08-11fiscal Q2 202036990001626199-20-000045
10-Q2020-05-14fiscal Q1 202034710001626199-20-000020
10-K2020-03-30fiscal FY 2019421040001626199-20-000009
10-Q2019-11-14fiscal Q3 2019391060001626199-19-000067
10-Q2019-08-13fiscal Q2 2019381020001626199-19-000055
10-Q2019-05-09fiscal Q1 201938780001626199-19-000040
10-K2019-03-18fiscal FY 2018401030001626199-19-000010
10-Q2018-11-08fiscal Q3 2018381070001626199-18-000018
10-Q2018-08-09fiscal Q2 201831830001626199-18-000012
10-Q2018-05-14fiscal Q1 201830630001626199-18-000004
10-K2018-03-28fiscal FY 201734840001564590-18-006916
10-Q2017-11-14fiscal Q3 201733900001564590-17-023636
10-Q2017-07-21fiscal Q2 201724580001558370-17-005234
10-Q2017-05-02fiscal Q1 201721430001558370-17-003278
10-K2017-02-13fiscal FY 201627960001558370-17-000560
10-Q2016-11-07fiscal Q3 201622550001558370-16-009534
10-Q2016-08-02fiscal Q2 201622550001558370-16-007132
10-Q2016-05-03fiscal Q1 201620420001558370-16-005215
10-K2016-03-08fiscal FY 2015291110001558370-16-003896
10-Q2015-11-03fiscal Q3 201525610001558370-15-002184
10-Q2015-08-04fiscal Q2 201523550001558370-15-001378

Inspect the source

Entity
ALPINE IMMUNE SCIENCES, INC. / CIK 0001626199
Captured
SEC response SHA-256
2a7df7fe63b5c267fe0cf9bef64742a505c8e4128001c3125621653d2bc29fc2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001626199.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))